Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology, Inc. (NASDAQ: ALGN) will present at the Stifel 2022 Jaws & Paws Conference on June 1, 2022, from 8:00 to 8:30 AM ET in New York, NY. The presentation will be webcast live on Align's Investor Relations website, with an archived replay available for approximately three months. This event will feature CEO Joe Hogan, CFO John Morici, and Corporate Communications Director Madelyn Valente. Align is known for its Invisalign system, iTero scanners, and exocad software, revolutionizing digital orthodontics and restorative dentistry for over 217,000 doctors and 12.8 million patients globally.
Align Technology announces a partnership with Asana to launch Asana Smiles™, a workflow solution tailored for Invisalign-trained doctors in the U.S. This platform allows dental practices to efficiently manage patients' treatment journeys, from consultations to aligner delivery. The solution is designed to integrate seamlessly with existing systems, enhancing practice efficiency and patient care. It will be showcased at the American Association of Orthodontists' Annual Session from May 21-24, 2022, and is set for release next month, with future expansion plans.
Align Technology has launched the Invisalign Outcome Simulator Pro, enhancing patient consultation through advanced visualization tools. Available on iTero Element Plus series scanners, it combines in-face simulations with 3D views of potential treatment outcomes, driving patient education and acceptance. This tool streamlines workflows and maximizes chair time for doctors, fostering efficiency. Dr. Johnathan Fitzpatrick emphasized its impact on treatment acceptance. The simulator will be featured at multiple upcoming conferences and is set for wider availability in the second half of 2022.
Align Technology (Nasdaq: ALGN) has announced a $200 million accelerated stock repurchase program with Citibank, part of its $1 billion repurchase initiative. The ASR will start with an initial buyback of approximately 552,000 shares, concluding by July 26, 2022. CEO Joe Hogan will additionally purchase $2 million in stock, reflecting confidence in Align's growth potential and market opportunities. The company holds approximately $1.1 billion in cash, supporting this strategic initiative aimed at enhancing shareholder value.
Align Technology reported Q1'22 total revenues of $973.2 million, up 8.8% year-over-year but down 5.6% sequentially. Q1'22 Clear Aligner revenues were $809.7 million, a 7.5% increase year-over-year but down 0.7% sequentially. The company faced challenges from COVID-19, inflation, and geopolitical issues, which affected volumes and margins. Despite these, Align remains optimistic about its market potential, targeting long-term revenue growth of 20-30%. The quarter had a diluted EPS of $1.70, with a non-GAAP EPS of $2.13.
Align Technology, Inc. (Nasdaq: ALGN) will release its first-quarter 2022 financial results on April 27, 2022, at 4:00 p.m. ET. A conference call will follow at 4:30 p.m. ET to discuss the results. Interested parties can access the call via phone or through a live audio webcast on Align's Investor Relations website. An archived version will be available later. Align Technology specializes in clear aligners, intraoral scanners, and CAD/CAM software for digital dentistry, having treated over 12.2 million patients with its Invisalign system.
Align Technology has announced the integration of Cone Beam Computed Tomography (CBCT) scan data into its ClinCheck treatment planning software. This feature enables orthodontists to visualize patients' roots, bones, and crowns in a 3D model, facilitating better treatment planning with Invisalign. This innovation allows for the management of complex cases and improves overall treatment outcomes. The feature is currently in technical design assessment and will be phased in across clients starting in late 2022.
Align Technology (ALGN) received notable recognition at the 2022 Institutional Investor’s Most Honored Companies Awards, with its CEO, CFO, and Investor Relations team ranked among the top in their categories. Joe Hogan placed third overall, while John Morici topped the Buy Side category. The Investor Relations program achieved second place in both Buy Side and Combined categories. Align's placement in the 'Most Honored Company' list reflects its effective communication and investor relations efforts during a challenging pandemic era.
Align Technology, Inc. (Nasdaq: ALGN) has settled its patent infringement and antitrust litigation with 3Shape A/S, which commenced in November 2017. The litigation included various claims in federal courts and before the United States Patent Trial and Appeal Board. The settlement terms are confidential, but it is not expected to materially affect Align's operations or financial results. Invisalign customers will still be able to use 3Shape scanners for case submissions outside the U.S., China, and Japan. Align remains committed to innovation in digital orthodontics.
Align Technology reported Q4 2021 revenues of $1.03 billion, a 23.6% year-over-year increase. Full year revenue reached $4.0 billion, up 59.9%. Clear Aligner revenue was $3.2 billion, while Imaging Systems and CAD/CAM Services rose to $705.5 million, marking increases of 54.5% and 90.4% respectively. Q4 diluted EPS stood at $2.40; non-GAAP diluted EPS was $2.83. The company achieved significant milestones, serving over 12 million Invisalign patients. Looking ahead, Align anticipates 2022 revenue growth of 20%-30% despite potential Omicron impacts.